Andrew Hykes - Oct 1, 2024 Form 4 Insider Report for Inari Medical, Inc. (NARI)

Role
President and CEO, Director
Signature
/s/ Shannon Trevino, attorney-in-fact for Andrew Hykes
Stock symbol
NARI
Transactions as of
Oct 1, 2024
Transactions value $
-$171,540
Form type
4
Date filed
10/3/2024, 04:36 PM
Previous filing
Aug 22, 2024
Next filing
Oct 31, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NARI Common Stock Tax liability -$20.6K -508 -0.11% $40.63 452K Oct 1, 2024 Direct F1
transaction NARI Common Stock Tax liability -$38.5K -947 -0.21% $40.63 451K Oct 1, 2024 Direct F2
transaction NARI Common Stock Tax liability -$59.9K -1.48K -0.33% $40.63 450K Oct 1, 2024 Direct F3
transaction NARI Common Stock Tax liability -$52.5K -1.29K -0.29% $40.63 448K Oct 1, 2024 Direct F4
holding NARI Common Stock 1.55K Oct 1, 2024 By Child 1
holding NARI Common Stock 1.55K Oct 1, 2024 By Child 2
holding NARI Common Stock 1.55K Oct 1, 2024 By Child 3
holding NARI Common Stock 1K Oct 1, 2024 By Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2021.
F2 Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2022.
F3 Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2023.
F4 Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2024.